Clinical Trial Details

Inclusion Criteria:

• Pathologically confirmed small cell lung cancer, limited or extensive stage.
• Patients who are offered thoracic radiotherapy with intensity-modulated proton therapy (IMPT) techniques delivering 30-66 Gy in 15-33 fractions at 2 Gy per fraction, at the recommendation of the treating radiation oncologist.
• Age 18 or greater

Exclusion Criteria:

• Prior radiation therapy which would provide significant dose overlap with the planned target volume(s)
• Pregnancy